Identification of Predictive Biomarkers for Response to Biologic Therapies in Inflammatory Bowel Disease
Conditions: Inflammatory Bowel Diseases; Crohn Disease; Ulcerative Colitis Intervention: Biological: Infliximab or adalimumab or golimumab or vedolizumab or ustekinumab Sponsor: Fundación de Investigación Biomédica - Hospital Universitario de La Princesa Not yet recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials